Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
37.4M
-
Number of holders
-
74
-
Total 13F shares, excl. options
-
23M
-
Shares change
-
+4.08M
-
Total reported value, excl. options
-
$171M
-
Value change
-
+$31.4M
-
Put/Call ratio
-
0.36
-
Number of buys
-
39
-
Number of sells
-
-37
-
Price
-
$7.43
Significant Holders of LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) as of Q4 2024
95 filings reported holding LFCR - LIFECORE BIOMEDICAL, INC. DE - Common Stock as of Q4 2024.
LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) has 74 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 23M shares
of 37.4M outstanding shares and own 61.55% of the company stock.
Largest 10 shareholders include WYNNEFIELD CAPITAL INC (4.7M shares), Legion Partners Asset Management, LLC (4.43M shares), Greenhaven Road Investment Management, L.P. (3.62M shares), 325 CAPITAL LLC (2.16M shares), BlackRock, Inc. (1.62M shares), VANGUARD GROUP INC (1.53M shares), MORGAN STANLEY (745K shares), GEODE CAPITAL MANAGEMENT, LLC (686K shares), Invesco Ltd. (556K shares), and DCF Advisers, LLC (540K shares).
This table shows the top 74 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.